Women lag men in receipt of kidney transplants, dialysis
(Reuters Health) – More men than women get kidney transplants and dialysis even though more women need these treatments for chronic kidney disease, a European...
Farage’s Brexit Party to fight every seat in poll battle with PM Johnson
Hardline Brexit advocate Nigel Farage opened his UK election campaign on Friday by telling Conservative prime minister Boris Johnson that his Brexit Party will contest...
Mali says at least 15 soldiers killed in militant attack
Fifteen Malian soldiers were killed in a militant attack on a military position in northern Mali on Friday, a spokesman for the army said, cautioning...
Trump nominates MD Anderson oncologist as U.S. FDA Commissioner
U.S. President Donald Trump has nominated Dr. Stephen Hahn, chief medical executive of the University of Texas MD Anderson Cancer Center, to lead the Food...
Bok captain Kolisi seeks gold for Rainbow Nation
South African rugby captain Siya Kolisi has become a symbol of unity for the country ahead of the Rugby World Cup final against England. Serena...
U.S. extends protected status for Hondurans in U.S. by a year: Honduran official
The U.S. government has extended temporary protection for Hondurans living in the United States by an additional year, the Honduran Foreign Minister Lisandro Rosales said...
Delta tankers says Brazil has not not contacted them over oil leak
Delta Tankers Ltd said on Friday that it has not been contacted by Brazilian authorities investigating an oil spill incident in Brazil....
Russia enacts ‘sovereign internet’ law, free speech activists cry foul
A law known as the “sovereign internet” bill came into force on Friday in Russia, tightening state control over the global network, which free speech...
Shippers seek alternatives for oil as crews work toward plugging Keystone leak
Cleanup crews in Walsh County, North Dakota, are working toward plugging the Keystone pipeline after a more than 9,000-barrel oil leak this week, a state...
Novartis says delayed telling FDA of Zolgensma concern due to ‘mistake’
Novartis scientists learnt months ago about safety concerns surrounding its gene therapy Zolgensma but delayed telling the U.S. Food and Drug Administration (FDA) due to...